Newsletter Header Image
This Week's Edition of BeakerBeat 
January 4, 2012  
Mike Justice
Mike Justice
News Director
BeakerBeat

 

While Santa stuffed stockings and Baby New Year arrived, much of the life sciences biz took a break over the holidays - but not Beaker - as we greet the new year we take a look back at the top stories in the life sciences industry from 2011. 

 

Our 2011 year-in-review show wouldn't be complete without some outtakes - we've got a gaggle of goof-ups to share, and most of them are Jeremy's fault.

 

All this and more on this week's edition of BeakerBeat. 

  Sponsored by Life Technologies          bb-010512  

 

Have a comment on this episode?    Contact Mike at BeakerBeat

 

Around the Watercooler

Key Stories from Around the Industry

 
Biogen Idec Inks $299 Million Deal for Isis Children's Drug
Posted: 1/3/2012


BioInvent and Servier Enter Oncology Collaboration
Posted: 1/3/2012


Welch Allyn President & CEO Announces Intention to Retire
Posted: 1/3/2012


Vermillion Plans to Reduce Headcount, Expenses
Posted: 1/3/2012


A look back at 2011
Posted: 1/3/2012


Health IT spending will grow $2B in the next 4 years
Posted: 1/3/2012


FDA: No off-label sharing in social media
Posted: 1/3/2012


What's driving patients' placebo effect?
Posted: 1/3/2012


VaxyGen Considers Building HQ in Atlanta; Move Could Create 250 New Jobs
Posted: 1/2/2012


Roche Scientist Provides a Look at Drugmaker's Early Pipeline
Posted: 1/2/2012


ISPE Announces as New CEO and President Succeeding Effective 1 January
Posted: 1/2/2012


Synthes Sues Stryker Over Trade Secrets, Raiding Sales Force
Posted: 1/2/2012

Beaker's Blog

   
Avastin comes up short again. Buyers remorse for Roche?
Posted: 1/3/2012


Personalized medicine: The emergence of companion diagnostics
Posted: 1/2/2012

Join Our Mailing List